BCM
KITE

Bayesian Capital Management’s Kite Pharma, Inc. KITE Stock Holding History

Bayesian Capital Management’s Portfolio KITE Stock Details KITE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-1,281
Closed -$230K – 822
2017
Q3 		$230K Buy
+1,281
New +$178K 0.05% 405

Bayesian Capital Management's KITE Position: Q4 2017 in Review

Bayesian Capital Management sold out of Kite Pharma, Inc. (KITE) in Q4 2017, closing a stake of 1,281 shares — an estimated $230K sold.

Bayesian Capital Management first reported a position in KITE in Q3 2017 and held it in 1 quarter. The position peaked at $230K in Q3 2017. 0 funds tracked by Wall St. Rank hold KITE as of Q4 2017.

  • Bayesian Capital Management reported no remaining Kite Pharma, Inc. position as of Q4 2017 after selling out during the quarter.
  • Bayesian Capital Management sold 1,281 Kite Pharma, Inc. shares in Q4 2017, an estimated $230K.
  • Bayesian Capital Management first reported a position in Kite Pharma, Inc. in Q3 2017 and held it in 1 quarter.
  • Bayesian Capital Management's Kite Pharma, Inc. position peaked at $230K in Q3 2017.
  • 0 funds tracked by Wall St. Rank held Kite Pharma, Inc. as of Q4 2017.

Based on Bayesian Capital Management's 13F filing for Q4 2017, filed 12 Feb 2018.